American Vanguard Corp.
) is leveraging strong market demand for soil insecticides as U.S.
corn growers contend with pest problems. The California-based maker
of diversified specialty chemicals has racked up five positive
earnings surprises in the past seven quarters, and its share price
has rocketed roughly 153% year-to-date.
With a projected long-term earnings growth of 25%, rising estimates
and favorable industry trends, this Zacks #1 Rank (Strong Buy)
stock is a good bet for aggressive growth investors.
American Vanguard Tops in Q2
On August 2, American Vanguard posted earnings of 30 cents per
share for the second-quarter 2012, topping the Zacks Consensus
Estimate by a nickel and exceeding last year's earnings of 22
cents. Profit surged 46% year over year to $8.7 million, buoyed by
higher demand for the company's soil fumigants and insecticides.
Revenues rose 6% year over year to $84.8 million. Gross margin
increased to 45.2% from 39.6% a year ago, aided by the company's
sales and marketing efforts and operational efficiency. Operating
margin rose to 16.8% from 13.3% in the prior-year quarter as higher
sales more than offset an increase in operating costs.
American Vanguard was relatively unaffected by the Midwest and
Southwest drought in the second quarter. The company envisions
continued demand for its post-harvest soil fumigants and cotton
insecticides in the third quarter.
Rising Earnings Estimates
The Zacks Consensus Estimate for 2012 has moved up roughly 3% in
the last 30 days to $1.15 per share, representing an estimated
annualized growth of around 44%. For 2013, the Zacks Consensus
Estimate rose by roughly 4% to $1.41 per share, indicating an
estimated growth of nearly 22%.
Valuation: Stretched but Warranted
American Vanguard trades at a significant premium to its peers by
most metrics. The company is currently trading at a forward P/E of
30.37x, a roughly 79.6% premium to the peer group average of
16.91x. Its trailing twelve months P/E of 35.02x is well above the
peer group average of 18.92x. The price-to-book of 4.74x is also
much higher than the peer group average of 1.84x. Moreover, the
price-to-sales of 2.96x is above the peer group average of 1.00x.
However, given the strong earnings trajectory, the premium
valuation should not scare investors away.
Strong Technicals The one-year chart below shows bullish technical
indicators for American Vanguard. The stock broke the 50-day moving
average twice, in late-November 2011 and early-August 2012. The
latter came on the heels of the strong second quarter results.
Moreover, the stock has been incessantly trading above the 200-day
moving average since November last year. Notably, the 50-day moving
average continues to read higher than the 200-day moving average,
with the 200-day moving average acting as the support level.
Founded in 1969, American Vanguard makes specialty chemical
products for agricultural and commercial applications. The company,
which competes with Aceto Corp. (
) and FMC Corp. (
), develops and markets an array of chemicals, including
insecticides, fungicides and herbicides, for crops, human and
animal health protection. American Vanguard, which has a market cap
of roughly $978 million, has the largest assortment of corn soil
insecticides coupled with the most advanced dispensing equipment.
Want More of Our Best Recommendations?
Zacks' Executive VP, Steve Reitmeister, knows when key trades are
about to be triggered and which of our experts has the hottest
hand. Then each week he hand-selects the most compelling trades and
serves them up to you in a new program called
AMER VANGUARD (AVD): Free Stock Analysis Report
To read this article on Zacks.com click here.